Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.
NIHR reports positive signs of recovery for the life sciences industry – Lifescience Industry News
Commercial research is showing clear signs of recovery since the pandemic according to the latest annual statistics reported by the NIHR Clinical Research Network (CRN).